Pete S Batra Selected Research

Pete S Batra Research Topics

Disease

21	Rhinosinusitis 10/2023 - 05/2006
14	Neoplasms (Cancer) 11/2022 - 07/2004
5	Inflammation (Inflammations) 11/2021 - 12/2007
5	Asthma (Bronchial Asthma) 10/2021 - 10/2003
4	Nasal Polyps (Nasal Polyp) 01/2020 - 10/2003
4	Mucocele 11/2011 - 05/2008
3	Polyps 10/2023 - 12/2007
3	Hypersensitivity (Allergy) 01/2021 - 12/2013
3	Allergic Rhinitis 01/2017 - 08/2010
3	Sinusitis 12/2007 - 10/2003
2	Bacterial Infections (Bacterial Infection) 01/2024 - 05/2010
2	Fibrosis (Cirrhosis) 01/2024 - 10/2021
2	Eosinophilia 10/2021 - 01/2019
2	COVID-19 11/2020 - 09/2020
2	Hemorrhage 11/2020 - 03/2005
2	Granuloma 03/2013 - 12/2012
2	Pathologic Constriction (Stenosis) 12/2012 - 11/2008
2	Cerebrospinal Fluid Leak 11/2010 - 02/2007
2	Nasal Obstruction 09/2009 - 05/2007
1	Polyploidy 10/2021
1	Rhinitis 01/2020
1	Rhinorrhea 01/2020
1	Eczema 01/2017
1	Anosmia 07/2016
1	Gastroesophageal Reflux (GERD) 01/2016
1	Carcinoma (Carcinomatosis) 05/2012
1	Neoplasm Metastasis (Metastasis) 11/2011
1	Allergic Fungal Sinusitis 09/2011
1	Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) 11/2010
1	Metabolic Bone Diseases (Osteopenia) 05/2010
1	Osteoporosis 05/2010
1	Epistaxis (Nosebleed) 11/2009
1	Hypertrophy 09/2009
1	Lacrimal Apparatus Diseases (Epiphora) 04/2009
1	Edema (Dropsy) 07/2008
1	Facial Pain (Myofacial Pain) 05/2007
1	Neurofibrosarcoma (MPNST) 05/2005

Drug/Important Bio-Agent (IBA)

5	SteroidsIBA 01/2022 - 10/2003
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021 - 10/2003
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2015 - 09/2013
2	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2007
2	Iron-Dextran Complex (InFed)FDA Link 01/2021 - 02/2016
2	CholesterolIBA 03/2013 - 12/2012
2	10-N-nonylacridinium orange (NAO)IBA 09/2009 - 05/2007
1	CoagulaseIBA 01/2024
1	OzoneIBA 11/2021
1	Air Pollutants (Pollutants, Air)IBA 11/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2021
1	Immunoglobulin E (IgE)IBA 10/2021
1	Particulate MatterIBA 01/2021
1	Irritants (Vesicants)IBA 11/2020
1	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 01/2020
1	Nasal SpraysIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	ORALIT (ORS)IBA 01/2016
1	Ketoconazole (Nizoral)FDA LinkGeneric 09/2011
1	Itraconazole (Sporanox)FDA LinkGeneric 09/2011
1	Fluorescein (Funduscein)FDA LinkGeneric 11/2010
1	Acetazolamide (Diamox)FDA LinkGeneric 11/2010
1	Histamine (Histamine Dihydrochloride)FDA Link 08/2010
1	Oxymetazoline FDA Link 08/2010
1	FluoroquinolonesIBA 05/2010
1	GlucocorticoidsIBA 05/2010
1	Prednisone (Sone)FDA LinkGeneric 07/2008
1	Budesonide (Pulmicort)FDA LinkGeneric 07/2008
1	bone waxIBA 05/2008
1	3-nitrotyrosineIBA 12/2007
1	Proteins (Proteins, Gene)FDA Link 12/2007
1	NitritesIBA 12/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2007
1	NitratesIBA 12/2007
1	Oxidants (Oxidizing Agents)IBA 12/2007
1	Arginine (L-Arginine)FDA Link 12/2007
1	Superoxide DismutaseIBA 12/2007
1	DNA (Deoxyribonucleic Acid)IBA 11/2007
1	Mupirocin (Bactroban)FDA LinkGeneric 05/2006

Therapy/Procedure

14	Therapeutics 01/2021 - 07/2004
2	Aftercare (After-Treatment) 11/2022 - 05/2012
2	Drug Therapy (Chemotherapy) 03/2015 - 11/2005
2	Craniotomy 11/2011 - 11/2005
2	Stents 11/2011 - 09/2008
2	Operative Surgical Procedures 11/2011 - 09/2008
2	Endoscopes 11/2010 - 03/2010
2	Operative Time 07/2007 - 09/2005
2	Computer-Assisted Surgery (Image Guided Surgery) 02/2007 - 11/2005
2	Hypophysectomy 02/2007 - 03/2005
2	Length of Stay 11/2005 - 09/2005
1	Biological Therapy 10/2023
1	Immunotherapy 01/2021
1	Extracorporeal Membrane Oxygenation 11/2020
1	Tracheostomy 09/2020
1	Personal Protective Equipment 09/2020
1	Cryosurgery 01/2020
1	Radiotherapy 10/2017
1	Reoperation 12/2012
1	Rhinoplasty 02/2012
1	Ligation 11/2009
1	Decompression 04/2009
1	Catheters 11/2008